 | • レポートコード：C-MOR-100271 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、動脈閉鎖デバイスの世界市場について調査・分析し、動脈閉鎖デバイスの世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The major factors attributing to the growth of the arteriotomy closure devices market are increasing incidences of vascular disorders and rising geriatric population. The global increase in the incidence of vascular diseases is due to a sedentary lifestyle, unhealthy diet, and smoking. Manual compression has been considered the traditional technique to achieve closure of the arterial access site. Patient comfort and satisfaction are the important factors that result in wide adoption of arteriotomy closure devices. Each year approximately 7 million invasive cardiovascular procedures are performed worldwide, this number is expected to increase with the aging population and act as a major driver for the growth of Arteriotomy Closure Devices market.
Scope of the Report
Arteriotomy Closure Devices (ACD) are widely used by surgeons to perform both diagnostic and interventional procedures. ACD are of two types: Active closure devices (Collagen plugs, Suture devices and clips) and Passive closure devices (compression devices and hemostasis pads). These closure devices are used to achieve hemostasis, improve patient outcome, and decrease vascular complications and hospitalization rate. Arterial access is usually obtained at the common femoral or radial artery.
Key Market Trends
Femoral Arterial Access is Highly Preferred in the Application Segment
The vast majority of procedures are performed with Femoral arterial access. However, increased interest has been observed for the radial approach due to the significant reduction in bleeding complications.
Vascular complications increase depending on the severity of the procedure. In order to reduce these complications, ACDs have been developed as an alternative to manual compression. The use of Arteriotomy Closure Devices is recommended to patients undergoing acute myocardial infarction, neurovascular interventions and endovascular procedures for peripheral vascular diseases. With the increasing incidence of vascular disorders as well as the development of innovative products, the growth of the market is expected to be augmented.
North America Dominates the Market and Expected to do the same in the Forecast Period
North America will witness the highest growth throughout the forecast period. This is due to the increasing prevalence of lifestyle disease, rising aging population and growing demand for newly introduced devices and innovative technologies. According to American College of Cardiology’s National Cardiovascular Data Registry (ACC-NCDR), less than 2% of invasive cardiovascular procedures are performed from the radial site, which indicates that the common femoral artery remains the most common arterial access site in the United States. In the North America region, the United States holds the largest market share.
Competitive Landscape
The Arteriotomy Closure Devices market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. Some of the major players of the market are Abbott Laboratories, Terumo Corporation, Cardinal Health, Cardiva Medical, Merit Medical, and Medtronic PLC, Teleflex, Vasorum Ltd, Vivasure Medical and Marine Polymer Technologies Inc. are among others.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Vascular disorders
4.2.2 Rising Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of the device
4.3.2 Risk Associated with the Procedure
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Products
5.1.1 Active Closure Devices
5.1.2 Passive Closure Devices
5.2 By Application
5.2.1 Femoral Arterial Access Procedures
5.2.2 Radial Arterial Access Procedures
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Care Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Cardinal Health
6.1.3 Cardiva Medical
6.1.4 Marine Polymer Technologies Inc
6.1.5 Medtronic PLC
6.1.6 Merit Medical
6.1.7 Teleflex Incorporated
6.1.8 Terumo Corporation
6.1.9 Vasorum Ltd
6.1.10 Vivasure Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS